Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds

Nazir MS, Ahmad M, Aslam S, Rafiq A, Al-Hussain SA, Zaki MEA

Drug Design, Development and Therapy 2024, 18:1547-1571

Published Date: 8 May 2024

A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK

Ma Y, Cui Q, Zhu W, Wang M, Zhai L, Hu W, Liu D, Liu M, Li Y, Li M, Han W

Drug Design, Development and Therapy 2024, 18:1531-1546

Published Date: 7 May 2024

ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis

Wang K, Kou Y, Rong X, Wei L, Li J, Liu H, Li M, Song H

Drug Design, Development and Therapy 2024, 18:1515-1528

Published Date: 6 May 2024


Read more articles